Literature DB >> 11434673

Evolving therapeutic strategies for acromegaly.

K H Darzy1, S M Shalet.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11434673     DOI: 10.1007/BF03351049

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  20 in total

1.  Outcome of surgery for acromegaly--the experience of a dedicated pituitary surgeon.

Authors:  N J Gittoes; M C Sheppard; A P Johnson; P M Stewart
Journal:  QJM       Date:  1999-12

2.  Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly.

Authors:  A L Barkan; I Halasz; K J Dornfeld; C A Jaffe; R D Friberg; W F Chandler; H M Sandler
Journal:  J Clin Endocrinol Metab       Date:  1997-10       Impact factor: 5.958

3.  Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy.

Authors:  A M Landolt; D Haller; N Lomax; S Scheib; O Schubiger; J Siegfried; G Wellis
Journal:  J Neurosurg       Date:  1998-06       Impact factor: 5.115

4.  Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly.

Authors:  N R Biermasz; H van Dulken; F Roelfsema
Journal:  J Clin Endocrinol Metab       Date:  2000-07       Impact factor: 5.958

5.  Results of a European multicentre study with Sandostatin LAR in acromegalic patients. Sandostatin LAR Group.

Authors:  I Lancranjan; A B Atkinson
Journal:  Pituitary       Date:  1999       Impact factor: 4.107

6.  Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience.

Authors:  S Ahmed; M Elsheikh; I M Stratton; R C Page; C B Adams; J A Wass
Journal:  Clin Endocrinol (Oxf)       Date:  1999-05       Impact factor: 3.478

7.  Low-dose pituitary irradiation for acromegaly.

Authors:  M D Littley; S M Shalet; R Swindell; C G Beardwell; M L Sutton
Journal:  Clin Endocrinol (Oxf)       Date:  1990-02       Impact factor: 3.478

Review 8.  Radiation therapy of acromegaly.

Authors:  R C Eastman; P Gorden; E Glatstein; J Roth
Journal:  Endocrinol Metab Clin North Am       Date:  1992-09       Impact factor: 4.741

9.  Determinants of clinical outcome and survival in acromegaly.

Authors:  C Rajasoorya; I M Holdaway; P Wrightson; D J Scott; H K Ibbertson
Journal:  Clin Endocrinol (Oxf)       Date:  1994-07       Impact factor: 3.478

10.  Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.

Authors:  B Swearingen; F G Barker; L Katznelson; B M Biller; S Grinspoon; A Klibanski; N Moayeri; P M Black; N T Zervas
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

View more
  1 in total

Review 1.  Octreotide long-acting release (LAR): a review of its use in the management of acromegaly.

Authors:  Kate McKeage; Susan Cheer; Antona J Wagstaff
Journal:  Drugs       Date:  2003       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.